|Table of Contents|

Research progress on the correlation between obesity and lung cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2025 06
Page:
1034-1038
Research Field:
Publishing date:

Info

Title:
Research progress on the correlation between obesity and lung cancer
Author(s):
HUANG LingZHAO MingdongMOU XiangQU XiaoyanLEI Jiawen
The Second People's Hospital Affiliated to Three Gorges University,Three Gorges University Endoscopic Minimally Invasive Medical Research Institute,Yichang Second People's Hospital,Hubei Yichang 443000,China.
Keywords:
obesitylung cancerBMIthe obesity paradox
PACS:
R734.2
DOI:
10.3969/j.issn.1672-4992.2025.06.021
Abstract:
Obesity and lung cancer are important public health issues that have attracted global attention.Although obesity has been identified as an important risk factor for various cancers such as esophageal cancer,breast cancer,and colon cancer,the relationship between obesity and lung cancer remains unclear.Most previous studies have suggested that obesity is not associated with lung cancer,and even has a certain protective effect.Obesity is associated with the use of drugs,smoking,obesity measurement methods,immune disorders and other confounding factors,resulting in this paradox.Due to the limitations of body mass index (BMI) in measuring obesity,it cannot accurately describe the distribution of body fat and cannot distinguish between fat and muscle content,which masks the potential impact of obesity on lung cancer patients.This hazard becomes apparent when obesity is measured as visceral obesity.In particular,the risk of lung cancer increased significantly when visceral obesity combined with low BMI,which is helpful to identify the high risk population of lung cancer.In clinical work,the selection of accurate obesity measurement methods and the timely assessment of the health status of patients will also provide a new direction for the prevention and treatment of lung cancer.The aim of this article is to analyze the factors leading to obesity paradox and its impact on lung cancer,and to further elaborate the correlation between obesity and lung cancer.

References:

[1] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] XIA C,DONG X,LI H,et al.Cancer statistics in China and United States,2022:profiles,trends,and determinants[J].Chin Med J (Engl),2022,135(5):584-590.
[3] WHARTON S,LAU DCW,VALLIS M,et al.Obesity in adults:a clinical practice guideline[J].CMAJ,2020,192(31):E875-E891.
[4] PAN XF,WANG L,PAN A.Epidemiology and determinants of obesity in China[J].Lancet Diabetes Endocrinol,2021,9(6):373-392.
[5] MIETHE S,KARSONOVA A,KARAULOA A,et al.Obesity and asthma[J].J Allergy Clin Immunol,2020,146(4):685-693.
[6] LI J,ZHU L,WEI Y,et al.Association between adiposity measures and COPD risk in Chinese adults[J].Eur Respir J,2020,55(4):1901899.
[7] MAIR KM,HARVEY KY,HENRY AD,et al.Obesity alters oestrogen metabolism and contributes to pulmonary arterial hypertension[J].Eur Respir J,2019,53(6):1801524.
[8] HONORE PM,GUTIERREZ LB,REDANT S,et al.Obesity ipopulation!nducing acute respiratory distress syndrome:we should choose the right[J].Crit Care,2019,23(1):328.
[9] ZHOU W,LIU G,HUNG RJ,et al.Causal relationships between body mass index,smoking and lung cancer:Univariable and multivariable Mendelian randomization[J].Int J Cancer,2021,148(5):1077-1086.
[10] PETRELLI F,CORTELLINI A,INDINI A,et al.Association of obesity with survival outcomes in patients with cancer:A systematic review and Meta-analysis[J].JAMA Netw Open,2021,4(3):e213520.
[11] SHEPSHELOVICH D,XU W,LU L,et al.Body mass index (BMI),BMI change,and overall survival in patients with SCLC and NSCLC:A pooled analysis of the international lung cancer consortium[J].J Thorac Oncol,2019,14(9):1594-1607.
[12] YOU D,WANG D,WU Y,et al.Associations of genetic risk,BMI trajectories,and the risk of non-small cell lung cancer:a population-based cohort study[J].BMC Med,2022,20(1):203.
[13] FINGERET M,MARQUES-VIDAL P,VOLLENWEIDER P.Incidence of type 2 diabetes,hypertension,and dyslipidemia in metabolically healthy obese and non-obese[J].Nutr Metab Cardiovasc Dis,2018,28(10):1036-1044.
[14] XIAO K,LIU F,LIU J,et al.The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus:A meta-analysis[J].J Clin Pharm Ther,2020,45(4):783-792.
[15] BARRIOS-BERNAL P,ZATARAIN-BARRON ZL,HERNANDEZ-PEDRO N,et al.Will we unlock the benefit of metformin for patients with lung cancer?Lessons from current evidence and new hypotheses[J].Pharmaceuticals (Basel),2022,15(7):786.
[16] YENDAMUEI S,BARBI J,PABLA S,et al.Body mass index influences the salutary effects of metformin on survival after lobectomy for stage I NSCLC[J].J Thorac Oncol,2019,14(12):2181-2187.
[17] WANG Y,HU Y,WANG T,et al.Addition of metformin for non-small cell lung cancer patients receiving antineoplastic agents[J].Front Pharmacol,2023,14:1123834.
[18] AMIN F,FATHI F,REINER Z,et al.The role of statins in lung cancer[J].Arch Med Sci,2021,18(1):141-152.
[19] ZHOU Q,JIAO Z,LIU Y,et al.The effects of statins in patients with advanced-stage cancers-a systematic review and meta-analysis[J].Front Oncol,2023,13:1234713.
[20] DE PERGOLA G,GIAGULLI VA,GUASTAMACCHIA E,et al.Platelet number is positively and independently associated with glycated hemoglobin in non-diabetic overweight and obese subjects[J].Nutr Metab Cardiovasc Dis,2019,29(3):254-259.
[21] GRANDE R,DOVIZIO M,MARCONE S,et al.Platelet-derived microparticles from obese individuals:Characterization of number,size,proteomics,and crosstalk with cancer and endothelial cells[J].Front Pharmacol,2019,10:7.
[22] SIMEONE P,LIANI R,TRIPALDI R,et al.Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes:Effects of liraglutide- or lifestyle changes-induced weight loss[J].Nutrients,2018,10(12):1872.
[23] LICHTENBERGER LM,VIJAYAN KV.Are platelets the primary target of aspirin's remarkable anticancer activity[J].Cancer Res,2019,79(15):3820-3823.
[24] ZHU Y,WEI Y,ZHANG R,et al.Elevated platelet count appears to be causally associated with increased risk of lung cancer:A mendelian randomization analysis[J].Cancer Epidemiol Biomarkers Prev,2019,28(5):935-942.
[25] DONG X,HE J,LIN L,et al.Association between aspirin use and lung cancer incidence depends on high-frequency use,bodyweight,and age in U.S. adults[J]. Transl Lung Cancer Res,2021,10(1):392-401.
[26] YU SY,IP MS,LI X,et al.Low-dose aspirin and incidence of lung carcinoma in patients with chronic obstructive pulmonary disease in Hong Kong:A cohort study[J].PLoS Med,2022,19(1):e1003880.
[27]KANG J,JEONG SM,SHIN DW,et al.The associations of aspirin,statins,and metformin with lung cancer risk and related mortality:A time-dependent analysis of population-based nationally representative data[J].J Thorac Oncol,2021,16(1):76-88.
[28] WATANABE T,TSUJINO I,KONNO S,et al.Association between smoking status and obesity in a nationwide survey of Japanese adults[J].PLoS One,2016,11(3):e0148926.
[29] TAYLOR AE,RICHMOND RC,PALVIAINEN T,et al.The effect of body mass index on smoking behaviour and nicotine metabolism:a Mendelian randomization study[J].Hum Mol Genet,2019,28(8):1322-1330.
[30] YAMAZAKI A,KINOSE D,KAWASHIMA S,et al.Predictors of longitudinal changes in body weight,muscle and fat in patients with and ever-smokers at risk of COPD[J].Respirology,2023,28(9):851-859.
[31] 闫焱,焦碧航,周昆,等.基线BMI与免疫检查点抑制剂治疗晚期非小细胞肺癌疗效的关系[J].郑州大学学报(医学版),2023,58(03):373-377. YAN Y,JIAO BH,ZHOU K,et al.Relationship between baseline body mass index and efficacy of immune checkpoint inhibitors in patients with advan ced non-small cell lung cancer [J].Journal of Zhengzhou University (Medical Edition),2023,58(03):373-377.
[32] OSTRAND-ROSENBERG S.Myeloid derived-suppressor cells:their role in cancer and obesity[J].Curr Opin Immunol,2018,51:68-75.
[33] ZENG Q,WANG L,DONG S,et al.CT-derived abdominal adiposity:Distributions and better predictive ability than BMI in a nationwide study of 59429 adults in China[J].Metabolism,2021,115:154456.
[34] DONINI LM,PINTO A,GIUSTI AM,et al.Obesity or BMI paradox?Beneath the tip of the iceberg[J].Front Nutr,2020,7:53.
[35] JEONG SM,LEE DH,GIOVANNUCCI EL.Predicted lean body mass,fat mass and risk of lung cancer:prospective US cohort study[J].Eur J Epidemiol,2019,34(12):1151-1160.
[36] OSWALT C,LIU Y,PANG H,et al.Associations between body mass index,weight loss and overall survival in patients with advanced lung cancer[J].J Cachexia Sarcopenia Muscle,2022,13(6):2650-2660.
[37] BARBERIO AM,ALAREEKIA,VINER B,et al.Central body fatness is a stronger predictor of cancer risk than overall body size[J].Nat Commun,2019,10(1):383.
[38] KOENEN M,HILL MA,COHEN P,et al.Obesity,adipose tissue and vascular dysfunction[J].Circ Res,2021,128(7):951-968.
[39] NEELAND IJ,ROSS R,DESPRES JP,et al.Visceral and ectopic fat,atherosclerosis,and cardiometabolic disease:a position statement[J].Lancet Diabetes Endocrinol,2019,7(9):715-725.
[40] 李岳航,王愿,李义帅,等.内脏脂肪在肺癌中的研究进展[J].实用医学杂志,2022,38(10):1292-1297. LI YH,WANG Y,LI YS,et al.Research progress of visceral fat in lung cancer[J].Journal of Practical Medicine,2022,38(10):1292-1297.
[41] ARDESCH FH,RUITER R,MULDER M,et al.The obesity paradox in lung cancer:Associations with body size versus body shape[J].Front Oncol,2020,10:591110.
[42] YU D,ZHENG W,JOHANSSON M,et al.Overall and central obesity and risk of lung cancer:A pooled analysis[J].J Natl Cancer Inst,2018,110(8):831-842.
[43] BARBI J,PATNAIK SK,PABLA S,et al.Visceral obesity promotes lung cancer progression-toward resolution of the obesity paradox in lung cancer[J].J Thorac Oncol,2021,16(8):1333-1348.
[44] NITSCHE L,VEDIRE Y,KANNISTO E,et al.Visceral obesity in non-small cell lung cancer[J].Cancers (Basel),2022,14(14):3450.
[45] CHRISTAKOUDI S,TSILIDIS KK,MULLER DC,et al.A body shape index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity:results from a large European cohort[J].Sci Rep,2020,10(1):14541.

Memo

Memo:
湖北省重点实验室开放基金(编号:2017KZL02)
Last Update: 1900-01-01